FundedIQ

Recently Funded Series A Biotechnology & Pharmaceuticals Startups

Updated Sep 2026

Funded Series A Biotechnology & Pharmaceuticals startups number 10 in FundedIQ, tracked with their funding rounds, amounts, investors, industries, locations and company details. This page provides an overview of the Series A Biotechnology & Pharmaceuticals startup funding landscape, along with the 10 most recently funded Series A Biotechnology & Pharmaceuticals startups.

Marseille and Austin hold the deepest concentrations of these companies. Series A Biotechnology & Pharmaceuticals startups closed 10 funding rounds over the last 24 months, 9 of them in the last 12 months, and raised $314M in disclosed capital. The median disclosed round is $23M, with the middle half of rounds falling between $18M and $64M.

Specialized venture capital firms dominate these rounds. The presence of strategic corporate investors indicates a preference for platforms with clear clinical paths. Capital is concentrated in the United States and China. This concentration means a high density of institutional oversight. Expect a heavy emphasis on intellectual property and regulatory milestones when engaging these firms.

Series A Biotechnology & Pharmaceuticals funded startup statistics

Funded Series A Biotechnology & Pharmaceuticals startups
10
tracked in the database
Funding rounds, last 12 months
9
10 over 24 months
Disclosed capital raised, 24 months
$314M
7 of 10 rounds disclosed an amount
Median round size
$23M
middle half $18M to $64M

Most recent funding round on record: Nov 2025.

10 most recently funded Series A Biotechnology & Pharmaceuticals startups

10 shown

Ordered by the date of the latest funding round. Each row gives the company, its location and industry, what it does, the stage and date of that round, and the disclosed amount.

B
Shanghai, China · Biotechnology, Pharmaceuticals
Brise Pharma operates in the scientific research and technical service industry.
Series A ·
$28M
N
Norn Gene
Chengdu, China · Biotechnology, Pharmaceuticals
Norn Gene is a nucleic acid drug delivery with its advanced LNP⊕ platform.
Series A ·
Undisclosed
B
San Francisco, United States · Biotechnology, Pharmaceuticals
Bexorg provides a technology platform for central nervous system drug discovery and development.
Series A ·
$23M
A
Marseille, France · Biotechnology, Pharmaceuticals
Adcytherix is a biopharmaceutical firm that specializes in the development of new antibody drug conjugates…
Series A ·
$122M
A
La Jolla, United States · Biotechnology, Pharmaceuticals
AeroRx Therapeutics is a biopharmaceutical company that developing proprietary, combination products.
Series A ·
$21M
A
Cambridge, United States · Biotechnology, Pharmaceuticals
AltrixBio is a pharmaceutical company focused on oral drug that replicates the metabolic success of bariatric…
Series A ·
$5.0M
T
Marseille, France · Biotechnology, Pharmaceuticals
Tafalgie Therapeutics is a CNRS and AMU spin-off company engaged in biopharmaceutical research.
Series A ·
$14M
M
Mondego Bio
Cantanhede, Portugal · Biotechnology, Pharmaceuticals
Mondego Bio is a new Portuguese startup developing breakthrough cancer treatments.
Series A ·
Undisclosed
O
Austin, United States · Biotechnology, Pharmaceuticals
Ollin Biosciences operates as a clinical-stage biopharmaceutical company.
Series A ·
$100M
R
RabPharma
Guangdong, China · Biotechnology, Pharmaceuticals
RabPharma specializes on the discovery and development of new drugs for bone and joint diseases.
Series A ·
Undisclosed

Countries with the most funded Series A Biotechnology & Pharmaceuticals startups

Where funded Series A Biotechnology & Pharmaceuticals startups are headquartered, by the country on the company record.

Country
Funded startups

Where are funded Series A Biotechnology & Pharmaceuticals startups located?

Where funded Series A Biotechnology & Pharmaceuticals startups are based, by the city on the company record.

About the FundedIQ Series A Biotechnology & Pharmaceuticals startup funding data

FundedIQ tracks announced startup funding rounds and organises them by company, funding date, stage, amount, industry, location and investor. The dataset is refreshed weekly, and new rounds are normalised and de-duplicated before they are published, so the same round reported twice on different dates is recorded once.

Figures on this page cover the 10 funded Series A Biotechnology & Pharmaceuticals startups currently tracked. Round counts, capital totals and the median round are computed over a trailing 24 months. Rounds whose amount was not disclosed (3 of 10 in that period) are counted as rounds but excluded from capital totals and from the median. The most recent round on record for funded Series A Biotechnology & Pharmaceuticals startups is dated Nov 2025.

The table above shows the 10 most recently funded companies. Full funding histories, investor lists and founder contacts across the whole dataset open on a FundedIQ plan.

Frequently asked questions

How many funded Series A Biotechnology & Pharmaceuticals startups are there?

FundedIQ tracks 10 funded Series A Biotechnology & Pharmaceuticals startups. This page lists the 10 most recently funded of them, ordered by the date of their latest round, and the full set is available on a FundedIQ plan.

How much funding have Series A Biotechnology & Pharmaceuticals startups raised?

Series A Biotechnology & Pharmaceuticals startups tracked by FundedIQ have raised $314M in disclosed capital across 10 funding rounds over the last 24 months, including 9 rounds in the last 12 months. 7 of those 10 rounds disclosed an amount; undisclosed rounds are excluded from the capital total.

Which countries have the most funded Series A Biotechnology & Pharmaceuticals startups?

United States leads with 4 companies, ahead of China (3), France (2) and Portugal (1).

Which cities have the most funded Series A Biotechnology & Pharmaceuticals startups?

Marseille leads with 2 companies, then Austin (1), Cambridge (1) and Cantanhede (1).

What is a typical funding round size for Series A Biotechnology & Pharmaceuticals startups?

The median disclosed round over the last 24 months is $23M, and the middle half of rounds fall between $18M and $64M. Round sizes vary widely by stage, so the seed and later-stage bands sit well either side of that figure.

How often is the Series A Biotechnology & Pharmaceuticals startup funding data updated?

The dataset is refreshed weekly. New rounds are normalised and de-duplicated before they are published, and the most recent round currently on record for funded Series A Biotechnology & Pharmaceuticals startups is dated Nov 2025. Counts and totals on this page are recomputed on every refresh.

Related listings

14-day free trial · Cancel anytime

Know who just raised. Then know who to reach.

Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.

Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.